Jiangsu Hengrui Medicine Co., Ltd.
600276
Pozycja w akcjach
#548
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Cena akcji
$6.89
Kapitalizacja rynkowa
$43.94B
Zmiana (1 dzień)
-2.91%
Zmiana (1 rok)
-24.78%
Kraj
CN
Handel Jiangsu Hengrui Medicine Co., Ltd. (600276)
Kategoria
Healthcare
Historia ceny akcji dla Jiangsu Hengrui Medicine Co., Ltd. (600276)
Najwyższa cena zamknięcia: $6.77 dnia 2026-10-01
Najniższa cena zamknięcia: $0.04 dnia 2005-07-01
Najniższa cena zamknięcia: $0.04 dnia 2005-07-01
Historia cen akcji firmy Jiangsu Hengrui Medicine Co., Ltd. od 2005 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -9.37% |
| 2025 | 33.70% |
| 2024 | 2.96% |
| 2023 | 15.17% |
| 2022 | -30.24% |
| 2021 | -37.82% |
| 2020 | 50.21% |
| 2019 | 73.88% |
| 2018 | 25.89% |
| 2017 | 85.51% |
| 2016 | 3.95% |
| 2015 | 100.95% |
| 2014 | 12.39% |
| 2013 | 42.52% |
| 2012 | 4.92% |
| 2011 | -16.03% |
| 2010 | 40.18% |
| 2009 | 61.62% |
| 2008 | -8.70% |
| 2007 | 153.91% |
| 2006 | 239.46% |
| 2005 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
